Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Oxprenolol hydrochloride

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Oxprenolol hydrochloride

EINECS 229-260-5
CAS No. 6452-73-9 Density N/A
PSA 50.72000 LogP 3.18200
Solubility N/A Melting Point 91-93 °C
Formula C15H24ClNO3 Boiling Point 403.3 °C at 760 mmHg
Molecular Weight 301.813 Flash Point 197.7 °C
Transport Information N/A Appearance White Solid
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 6452-73-9 (Oxprenolol hydrochloride) Hazard Symbols IrritantXi
Synonyms

2-Propanol,1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, hydrochloride (9CI);2-Propanol, 1-[o-(allyloxy)phenoxy]-3-(isopropylamino)-, hydrochloride(7CI,8CI);1-(2-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride;1-(2'-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride;1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride;1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propranol-hydrochloride;1-Isopropyl-amino-2-hydroxy-3-(O-allyloxyphenoxy)propanehydrochloride;1-Isopropylamino-3-(o-allyloxyphenoxy)-2-propanol hydrochloride;Ba 39089;CIBA 39089Ba;Laracor;Oxiprenolol hydrochloride;Oxprenololhydrochloride;Paritane;Slow-Pren;Slow-Trasicor;Trasacor;Trasicor;Trasicor80;dl-Alprenolol hydrochloride;dl-Oxprenolol hydrochloride;

 

Oxprenolol hydrochloride Specification

The Oxprenolol hydrochloride, with the CAS registry number 6452-73-9, is also known as 2-Propanol,1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-, hydrochloride (1:1). It belongs to the product categories of Amines; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS number is 229-260-5. This chemical's molecular formula is C15H24ClNO3 and molecular weight is 301.81. What's more, its systematic name is 1-[2-(Allyloxy)phenoxy]-3-(isopropylamino)-2-propanol hydrochloride (1:1). Its classification codes are: (1)Drug / Therapeutic Agent (2)Human Data (3)Reproductive Effect (4)Vasodilator [coronary]. This chemical is a beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias and anxiety.

Physical properties of Oxprenolol hydrochloride are: (1)ACD/LogP: 2.291; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.73; (4)ACD/LogD (pH 7.4): 0.44; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 5.94; (9)#H bond acceptors: 4; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 10; (12)Polar Surface Area: 30.93 Å2; (13)Flash Point: 197.7 °C; (14)Enthalpy of Vaporization: 69.02 kJ/mol; (15)Boiling Point: 403.3 °C at 760 mmHg; (16)Vapour Pressure: 3.15E-07 mmHg at 25°C.

Uses of Oxprenolol hydrochloride: it can be used to produce N-nitrosooxprenolol at the temperature of 50 °C. It will need reagents sodium nitrite, aq. HCl with the reaction time of 5 hours. The yield is about 85%.

Oxprenolol hydrochloride can be used to produce N-nitrosooxprenolol at the temperature of 50 °C

When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need to wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl
(2)InChI: InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H
(3)InChIKey: COAJXCLTPGGDAJ-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD90 oral 200mg/kg (200mg/kg) CARDIAC: PULSE RATE

BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
dog LD50 intravenous 15mg/kg (15mg/kg) BEHAVIORAL: TREMOR

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BEHAVIORAL: ATAXIA
Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1890, 1970.
dog LDLo oral > 30mg/kg (30mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
dog LDLo subcutaneous > 30mg/kg (30mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
mouse LD50 intraperitoneal 170mg/kg (170mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SLEEP
Polish Journal of Pharmacology and Pharmacy. Vol. 25, Pg. 151, 1973.
mouse LD50 intravenous 20mg/kg (20mg/kg) AUTONOMIC NERVOUS SYSTEM: SYMPATHOMIMETIC Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 1022, 1977.
mouse LD50 oral 520mg/kg (520mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3131, 1973.
mouse LD50 subcutaneous 245mg/kg (245mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ATAXIA
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
rabbit LDLo intravenous 20mg/kg (20mg/kg) BEHAVIORAL: ATAXIA

CARDIAC: OTHER CHANGES

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1890, 1970.
rat LD50 intraperitoneal 147mg/kg (147mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3131, 1973.
rat LD50 intravenous 33mg/kg (33mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
rat LD50 oral 214mg/kg (214mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 35, Pg. 1236, 1985.
rat LD50 subcutaneous 940mg/kg (940mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968.
women LDLo oral 90mg/kg (90mg/kg) LUNGS, THORAX, OR RESPIRATION: CYANOSIS

BEHAVIORAL: GENERAL ANESTHETIC

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)
British Medical Journal. Vol. 1, Pg. 552, 1977.
women TDLo oral 160mg/kg (160mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA

VASCULAR: SHOCK
Human & Experimental Toxicology. Vol. 9, Pg. 101, 1990.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6452-73-9